343 related articles for article (PubMed ID: 34944495)
1. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
Bharadwaj A; Kempster E; Waisman DM
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
[TBL] [Abstract][Full Text] [Related]
2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of plasmin generation by S100A10.
Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
He KL; Deora AB; Xiong H; Ling Q; Weksler BB; Niesvizky R; Hajjar KA
J Biol Chem; 2008 Jul; 283(28):19192-200. PubMed ID: 18434302
[TBL] [Abstract][Full Text] [Related]
6. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
Bydoun M; Waisman DM
Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
[TBL] [Abstract][Full Text] [Related]
7. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
Bharadwaj AG; Kempster E; Waisman DM
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.
Zhang Y; Zhou ZH; Bugge TH; Wahl LM
J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546
[TBL] [Abstract][Full Text] [Related]
9. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
[TBL] [Abstract][Full Text] [Related]
10. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
[TBL] [Abstract][Full Text] [Related]
11. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes.
Laumonnier Y; Syrovets T; Burysek L; Simmet T
Blood; 2006 Apr; 107(8):3342-9. PubMed ID: 16373665
[TBL] [Abstract][Full Text] [Related]
12. The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair.
Rezvanpour A; Santamaria-Kisiel L; Shaw GS
J Biol Chem; 2011 Nov; 286(46):40174-83. PubMed ID: 21949189
[TBL] [Abstract][Full Text] [Related]
13. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
[TBL] [Abstract][Full Text] [Related]
14. S100A10/p11: family, friends and functions.
Rescher U; Gerke V
Pflugers Arch; 2008 Jan; 455(4):575-82. PubMed ID: 17638009
[TBL] [Abstract][Full Text] [Related]
15. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Noye TM; Lokman NA; Oehler MK; Ricciardelli C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
[TBL] [Abstract][Full Text] [Related]
16. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARĪ± fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CFTR function by annexin A2-S100A10 complex in health and disease.
Muimo R
Gen Physiol Biophys; 2009; 28 Spec No Focus():F14-9. PubMed ID: 20093721
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Ion Channels and Receptors by p11 (S100A10).
Seo JS; Svenningsson P
Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
20. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.
Zhang L; Fogg DK; Waisman DM
J Biol Chem; 2004 Jan; 279(3):2053-62. PubMed ID: 14570893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
